Research focus
About the research
How do cell surface and secreted proteins govern T cell activation, tolerance, memory, and survival?
Read the full research overview
Lieping Chen is an immunologist and physician-scientist at Yale. His research focuses on basic T cell biology and the translation of laboratory discoveries into clinical therapies. The work has a primary emphasis on cancer immunotherapy, and the laboratory is renowned for the 1999 discovery of the B7-H1 (PD-L1) molecule. His laboratory identified the PD-1/PD-L1 pathway as a mechanism of immune evasion within the tumor microenvironment.
Selected publications
3 listedResistance Mechanisms to Anti-PD Cancer Immunotherapy
Annual Review of Immunology
Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities
Nature Reviews Drug Discovery
Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy
Science Translational Medicine
People & alumni
Team details haven’t been added. See the lab’s website for its current members.
Alumni details haven’t been added. Check the lab’s official website.
Sources & listing information
Find Research Labs maintains this page using public sources. The faculty member, lab, and university have not claimed or approved this listing. Listing a lab does not indicate endorsement, partnership, or a recruiting opportunity.
Request a correction or removal ↗ · About directory listings